These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24364871)

  • 1. Enhanced oral bioavailability of the antiretroviral efavirenz encapsulated in poly(epsilon-caprolactone) nanoparticles by a spray-drying method.
    Tshweu L; Katata L; Kalombo L; Chiappetta DA; Hocht C; Sosnik A; Swai H
    Nanomedicine (Lond); 2014; 9(12):1821-33. PubMed ID: 24364871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailability [corrected].
    Chiappetta DA; Hocht C; Taira C; Sosnik A
    Nanomedicine (Lond); 2010 Jan; 5(1):11-23. PubMed ID: 20025460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation.
    Patel GV; Patel VB; Pathak A; Rajput SJ
    Drug Dev Ind Pharm; 2014 Jan; 40(1):80-91. PubMed ID: 23323843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(ε-caprolactone), Eudragit® RS 100 and poly(ε-caprolactone)/Eudragit® RS 100 blend submicron particles for the sustained release of the antiretroviral efavirenz.
    Seremeta KP; Chiappetta DA; Sosnik A
    Colloids Surf B Biointerfaces; 2013 Feb; 102():441-9. PubMed ID: 23010128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An oral formulation of efavirenz-loaded lactoferrin nanoparticles with improved biodistribution and pharmacokinetic profile.
    Kumar P; Lakshmi YS; Kondapi AK
    HIV Med; 2017 Aug; 18(7):452-462. PubMed ID: 28000390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
    Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
    J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced anticancer activity and oral bioavailability of ellagic acid through encapsulation in biodegradable polymeric nanoparticles.
    Mady FM; Shaker MA
    Int J Nanomedicine; 2017; 12():7405-7417. PubMed ID: 29066891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti HIV nanoemulsion formulation: optimization and in vitro-in vivo evaluation.
    Kotta S; Khan AW; Ansari SH; Sharma RK; Ali J
    Int J Pharm; 2014 Feb; 462(1-2):129-34. PubMed ID: 24374067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and investigation of high solid content PTX-loaded nanoparticles dispersion via nanoprecipitation method.
    Xiang Y; Xiao M; Han S; Xu S; Cao Y; Lv Z; Liu J; Liu J; Deng L; Dong A
    J Biomater Sci Polym Ed; 2014; 25(11):1144-58. PubMed ID: 24894948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between microstructure and bioequivalence in anti-HIV drug efavirenz.
    Fandaruff C; Segatto Silva MA; Galindo Bedor DC; de Santana DP; Rocha HV; Rebuffi L; Azanza Ricardo CL; Scardi P; Cuffini SL
    Eur J Pharm Biopharm; 2015 Apr; 91():52-8. PubMed ID: 25661587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral pharmacokinetics of the anti-HIV efavirenz encapsulated within polymeric micelles.
    Chiappetta DA; Hocht C; Taira C; Sosnik A
    Biomaterials; 2011 Mar; 32(9):2379-87. PubMed ID: 21186055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncovalent PEG Coating of Nanoparticle Drug Carriers Improves the Local Pharmacokinetics of Rectal Anti-HIV Microbicides.
    Nunes R; Araújo F; Barreiros L; Bártolo I; Segundo MA; Taveira N; Sarmento B; das Neves J
    ACS Appl Mater Interfaces; 2018 Oct; 10(41):34942-34953. PubMed ID: 30234288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly (ε-caprolactone) nanocapsules for oral delivery of raloxifene: process optimization by hybrid design approach, in vitro and in vivo evaluation.
    Aditya N; Ravi PR; Avula US; Vats R
    J Microencapsul; 2014; 31(5):508-18. PubMed ID: 24697167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles.
    Jin X; Huang A; Ping Q; Cao F; Su Z
    Pharmazie; 2011 May; 66(5):339-47. PubMed ID: 21699067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spray-dried didanosine-loaded polymeric particles for enhanced oral bioavailability.
    Seremeta KP; Tur MI; Pérez SM; Höcht C; Taira C; López Hernández OD; Sosnik A
    Colloids Surf B Biointerfaces; 2014 Nov; 123():515-23. PubMed ID: 25444665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral delivery of capsaicin using MPEG-PCL nanoparticles.
    Peng W; Jiang XY; Zhu Y; Omari-Siaw E; Deng WW; Yu JN; Xu XM; Zhang WM
    Acta Pharmacol Sin; 2015 Jan; 36(1):139-48. PubMed ID: 25434988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
    Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
    Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rifampicin-loaded 'flower-like' polymeric micelles for enhanced oral bioavailability in an extemporaneous liquid fixed-dose combination with isoniazid.
    Moretton MA; Hocht C; Taira C; Sosnik A
    Nanomedicine (Lond); 2014 Aug; 9(11):1635-50. PubMed ID: 24410279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-lasting anti-platelet activity of cilostazol from poly(ε-caprolactone)-poly(ethylene glycol) blend nanocapsules.
    Gomes MLS; da Silva Nascimento N; Borsato DM; Pretes AP; Nadal JM; Novatski A; Gomes RZ; Fernandes D; Farago PV; Zanin SMW
    Mater Sci Eng C Mater Biol Appl; 2019 Jan; 94():694-702. PubMed ID: 30423756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles-in-film for the combined vaginal delivery of anti-HIV microbicide drugs.
    Cunha-Reis C; Machado A; Barreiros L; Araújo F; Nunes R; Seabra V; Ferreira D; Segundo MA; Sarmento B; das Neves J
    J Control Release; 2016 Dec; 243():43-53. PubMed ID: 27664327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.